Inactivating mutation in the cell cycle regulator locus CDKN2A subsequently promotes a neurofibroma’s progression into a pre-malignant state called atypical neurofibroma of uncertain potential (ANNUBP). This evidence concerns the gene CDKN2A and neurofibroma.